StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Lipella Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2025 was -1387.9%. For fiscal 2024 it was -947.2%, against -1055.6% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-947.2%+108.3
FY2023Dec 31, 2023-1055.6%+350.7
FY2022Dec 31, 2022-1406.3%−667.5
FY2021Dec 31, 2021-738.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2025Jun 30, 2025-1564.2%−866.3
Q1 FY2025Mar 31, 2025-1026.2%−191.5
Q4 FY2024Dec 31, 2024-835.7%−231.9
Q3 FY2024Sep 30, 2024-1815.6%−511.7
Q2 FY2024Jun 30, 2024-697.9%+778.7
Q1 FY2024Mar 31, 2024-834.7%+83.9
Q4 FY2023Dec 31, 2023-603.8%−365.8
Q3 FY2023Sep 30, 2023-1303.9%+918.4
Q2 FY2023Jun 30, 2023-1476.6%–
Q1 FY2023Mar 31, 2023-918.6%–
Q4 FY2022Dec 31, 2022-237.9%–
Q1 FY2022Mar 31, 2022-2222.3%–

More Lipella Pharmaceuticals figures

See a number that looks wrong?